RAAS inhibitors in patients undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry

Back

ESC Professional Premium Access

RAAS inhibitors in patients undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry

Session: Clinical pharmacology

Topic: Angiotensin-Renin-Bradykinin System

Speaker: Doctor C. Basile (Naples, IT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Christian Basile

University of Naples Federico II, Naples (Italy)

1 presentation

1 follower

7 more presentations in this session

Temporal trends of first time antihypertensive treatment among citizens over 75 years - a register-based, cohort study

Speaker: Mr S. Nielsen (Hellerup, DK)

Targeting liver angiotensinogen using a GalNAc-siRNA improves cardiac remodeling in spontaneously hypertensive rats

Speaker: Doctor J. Wikstrom (SE)

Amiodarone induced thyroid dysfunction.

Speaker: Doctor P. Gudjonsson (Reykjavik, IS)

Xanthine oxidase inhibitors withdrawal syndrome

Speaker: Doctor M. Kuwabara (Shimotsuke, JP)

Amiodarone and the risk for pulmonary fibrosis. A Danish nationwide study.

Speaker: Doctor B. Al-Abbasi (Roskilde, DK)

Access the full session

Clinical pharmacology

Speakers: Doctor C. Basile, Mr S. Nielsen, Doctor J. Wikstrom, Doctor P. Gudjonsson, Doctor M. Kuwabara...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources